See What’s Possible in Life Sciences Packaging @ PACK EXPO International
2,700 exhibitors. 150+ free educational sessions. See packaging solutions for life sciences & more @ PACK EXPO International, Oct 18-21 in Chicago
REGISTER NOW

Create a free Healthcare Packaging account to continue reading

Tamiflu (oseltamivir) for Oral Suspension: Potential Medication Errors*

FDA issued a Public Health Alert to notify prescribers and pharmacists about potential dosing errors with Tamiflu (oseltamivir) for Oral Suspension.

U.S. health care providers usually write prescriptions for liquid medicines in milliliters (mL) or teaspoons, while Tamiflu is dosed in milligrams (mg). The dosing dispenser packaged with Tamiflu has markings only in 30, 45 and 60 mg. The Agency has received reports of errors where dosing instructions for the patient do not match the dosing dispenser. Health care providers should write doses in mg if the dosing dispenser with the drug is in mg. Pharmacists should ensure that the units of measure on the prescription instructions match the dosing device provided with the drug.
See What’s Possible in Life Sciences Packaging at PACK EXPO International
Explore new machinery & materials from 2,700 exhibitors. Gain insights from 150+ free educational sessions. Find solutions to tackle the toughest challenges—for life sciences & beyond—at North America’s largest packaging & processing event.
REGISTER NOW
See What’s Possible in Life Sciences Packaging at PACK EXPO International